IUPAC/Chemical Name
1,1-Ethenediamine, N-(1,3-benzodioxol-5-ylmethyl)-N'-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-2-nitro-
InChi Key
HXRSXEDVVARPHP-NDENLUEZSA-N
InChi Code
InChI=1S/C20H26N4O5S/c1-23(2)11-16-4-5-17(29-16)13-30-8-7-21-20(12-24(25)26)22-10-15-3-6-18-19(9-15)28-14-27-18/h3-6,9,12,21-22H,7-8,10-11,13-14H2,1-2H3/b20-12-
SMILES Code
O=[N+](/C=C(NCCSCC1=CC=C(CN(C)C)O1)\NCC2=CC=C(OCO3)C3=C2)[O-]
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
434.51
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Palasciano G, Maggi V, Portincasa P. The effect of the H2-antagonist niperotidine on intragastric acidity in healthy subjects undergoing 24-hour pH- monitoring. Ital J Gastroenterol. 1990 Oct;22(5):291-4. PMID: 1983712.
2: Gasbarrini G, Gentiloni N, Febbraro S, Gasbarrini A, Di Campli C, Cesana M, Miglio F, Miglioli M, Ghinelli F, D'Ambrosi A, Amoroso P, Pacini F, Salvadori G. Acute liver injury related to the use of niperotidine. J Hepatol. 1997 Sep;27(3):583-6. doi: 10.1016/s0168-8278(97)80365-0. PMID: 9314138.
3: Mannino S, Troncon MG, Wallander MA, Cattaruzzi C, Romano F, Agostinis L, Marighi PE, Walker A. Ocular disorders in users of H2 antagonists and of omeprazole. Pharmacoepidemiol Drug Saf. 1998 Jul;7(4):233-41. doi: 10.1002/(SICI)1099-1557(199807/08)7:4<233::AID-PDS336>3.0.CO;2-R. PMID: 15073985.